Actimmune Interactions
There are 198 drugs known to interact with Actimmune (interferon gamma-1b), along with 3 disease interactions. Of the total drug interactions, 37 are major, 160 are moderate, and 1 is minor.
- View all 198 medications that may interact with Actimmune
- View Actimmune disease interactions (3)
Most frequently checked interactions
View interaction reports for Actimmune (interferon gamma-1b) and the medicines listed below.
- acetaminophen
- Adagen (pegademase bovine)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Cymbalta (duloxetine)
- Darzalex Faspro (daratumumab / hyaluronidase)
- Emgality (galcanezumab)
- Esbriet (pirfenidone)
- Evrysdi (risdiplam)
- Imbruvica (ibrutinib)
- Letairis (ambrisentan)
- Luxturna (voretigene neparvovec ophthalmic)
- Mayzent (siponimod)
- Ocrevus (ocrelizumab)
- Ofev (nintedanib)
- Opsumit (macitentan)
- Repatha (evolocumab)
- Rybelsus (semaglutide)
- Savella (milnacipran)
- Spinraza (nusinersen)
- Stelara (ustekinumab)
- Taltz (ixekizumab)
- Tecfidera (dimethyl fumarate)
- Trikafta (elexacaftor / ivacaftor / tezacaftor)
- Venclexta (venetoclax)
- Vyndaqel (tafamidis)
- Xgeva (denosumab)
Actimmune disease interactions
There are 3 disease interactions with Actimmune (interferon gamma-1b) which include:
Report options
QR code containing a link to this page
More about Actimmune (interferon gamma-1b)
- Actimmune consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: interferons
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.